When a person becomes ill and needs medication, in most cases they can easily obtain a prescription drug that will treat their ailment. However, even with the best health insurance available, some conditions can't be treated because they are resistant to frequently used medications.

The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority recently announced they are awarding funds worth between $27 and $464 million in contracts to help support research of antibiotics used to fight bioterrorism and antibiotic resistant infections.

"This new antibiotic is part of our push against antibiotic resistance for certain bacterial infections, and at the same time could provide a new treatment for plague and tularemia biothreats," said BARDA Director Dr. Robin Robinson. "It's the first time BARDA research and development funds have been used in a multi-use approach like this."

The National Network for Immunization Information says antibiotic resistance is growing in common illnesses such as meningitis and pneumonia. They cite the frequent use of antibiotics, sometimes when not necessary, for the growing level of resistance.